KL

Kiran Lata

Active Director Director DIN 08517243
DIN 08517243 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Kiran Lata

Data last updated:

Kiran Lata is a Director at Glowrays Pharma Private Limited (since 2019). The company operates in Healthcare. Glowrays Pharma Private Limited reported revenue of ₹4.7 Lakh (FY 2025).

DIN 08517243
Primary Designation Director
Industry Healthcare
First Appointment 22 Jul 2019
Oldest Company Age 7 yrs
Largest company Glowrays Pharma Private Limited · ₹4.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glowrays Pharma Private Limited U85100HR2019PTC081599
Director22 Jul 20192019₹4.7 Lakh (FY 2025)Active

Board colleagues of Kiran Lata

NameDINCompanyDesignation
Ram Murti Kevat10481316Glowrays Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glowrays Pharma Private Limited
Premium access

Shareholding and investment profile for Kiran Lata

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Lata

Kiran Lata currently holds 1 directorship: Glowrays Pharma Private Limited (Director, since 22 Jul 2019, revenue ₹4.7 Lakh (FY 2025)).

Kiran Lata was first appointed on 22 Jul 2019 as Director at Glowrays Pharma Private Limited.

The current boards of Kiran Lata's companies include Ram Murti Kevat (Glowrays Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available